UMR 5305, Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique CNRS / University of Lyon, 69367 Lyon, France.
UMR 5305, Laboratoire de Biologie Tissulaire et Ingénierie Thérapeutique CNRS / University of Lyon, 69367 Lyon, France.
Matrix Biol. 2015 May-Jul;44-46:14-23. doi: 10.1016/j.matbio.2015.02.006. Epub 2015 Feb 18.
Bone morphogenetic protein-1 (BMP-1)/tolloid-like proteinases, here called BTPs, include the proteases originally identified for their roles in the C-terminal maturation of fibrillar procollagens ("procollagen C-proteinase"). Though numerous other substrates have since been discovered, the BTPs remain the main proteases involved in extracellular matrix assembly with little or no implication in matrix degradation. During the same period however, the BTPs have also become established as important proteases in the activation of growth factors, including TGF-β1, BMP-2/-4, GDF-8/-11 and IGFs, as well as the release of anti-angiogenic fragments from parent proteins. The BTPs are therefore key players in many pathophysiological processes such as morphogenesis, tissue repair and tumor progression. This mini-review summarizes our current knowledge of the functions of BTPs, their substrates and unusual mechanisms of regulation, and discusses their potential as new targets for future therapies.
骨形态发生蛋白-1(BMP-1)/tolloid 样蛋白酶,以下简称 BTPs,包括最初因其在纤维状原胶原 C 端成熟中的作用而被鉴定的蛋白酶(“原胶原 C 蛋白酶”)。尽管此后发现了许多其他底物,但 BTPs 仍然是参与细胞外基质组装的主要蛋白酶,几乎没有或没有涉及基质降解。然而,在同一时期,BTPs 也已成为 TGF-β1、BMP-2/-4、GDF-8/-11 和 IGFs 等生长因子激活以及从母体蛋白释放抗血管生成片段的重要蛋白酶。BTPs 因此是许多病理生理过程中的关键参与者,如形态发生、组织修复和肿瘤进展。这篇迷你综述总结了我们目前对 BTPs 的功能、其底物和不寻常的调节机制的了解,并讨论了它们作为未来治疗新靶点的潜力。